← Open Payments lookup

MARK ESCHE: Open Payments

NPI 1174622740 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,739 in 149 payments from 14 companies in 2025. Trend: 2023 $2,650 · 2024 $2,347 · 2025 $2,739

Food & beverage: $2,737Education: $1
CompanyPaymentsAmount
Alkermes, Inc.42$722
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$497
Otsuka America Pharmaceutical, Inc.18$357
ABBVIE INC.20$307
Takeda Pharmaceuticals U.S.A., Inc.12$187
Axsome Therapeutics, Inc.8$173
Lundbeck LLC7$133
Neurocrine BioSciences, Inc.5$95
Collegium Pharmaceutical, Inc.5$79
Teva Pharmaceuticals USA, Inc.3$78

Products named: ARISTADA, CAPLYTA, REXULTI, VRAYLAR, TRINTELLIX, Auvelity, ABILIFY ASIMTUFII, INGREZZA.

Industry payments across TX — which companies pay providers there.